PSB-CB5

• Description:

  PSB-CB5 is a potent and selective antagonist of GRP18. PSB-CB5 has the potential for the research of metabolic disease and obesity[1].

• UNSPSC:

  12352005

• Target:

  Cannabinoid Receptor

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein; Neuronal Signaling

• Applications:

  Metabolism-protein/nucleotide metabolism

• Field of Research:

  Metabolic Disease

• Assay Protocol:

  https://www.medchemexpress.com/psb-cb5.html

• Purity:

  95.0

• Solubility:

  10 mM in DMSO|DMSO : ≥ 2mg/mL

• Smiles:

  O=C(N1C(SCCC1)=N/2)C2=C\C3=CC=CC(OCC4=CC=C(Cl)C=C4)=C3

• Molecular Formula:

  C20H17ClN2O2S

• Molecular Weight:

  384.88

• References & Citations:

  [1]Kotańska M, et al. Effects of GPR18 Ligands on Body Weight and Metabolic Parameters in a Female Rat Model of Excessive Eating. Pharmaceuticals (Basel) . 2021;14 (3) :270.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -20°C, 3 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [1627710-30-8]